Combination Therapy for the Treatment of Arterial Hypertension

被引：0

作者：

Watschinger, B. ^{[1
]}

机构：

[1] Med Univ Wien, Univ Klin Innere Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

来源：

JOURNAL FUR HYPERTONIE | 2010年 / 14卷

关键词：

Arterial hypertension; blood pressure control; combination therapy;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

An increasing number of drugs are available for the treatment of arterial hypertension, providing the option for an even greater number of possible combinations in order to reach the treatment targets for blood pressure. As hypertension is still not well-controlled in the population, combination therapies are now the focus of therapeutic considerations. Recent evidence from controlled studies suggests that combination therapies are superior to monotherapies in preventing cardiovascular events and mortality.

引用

页码：7 / 16

页数：10

共 43 条

[1] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial [J].

Bakris, GL ;

Fonseca, V ;

Katholi, RE ;

McGill, JB ;

Messerli, FH ;

Phillips, RA ;

Raskin, P ;

Wright, JT ;

Oakes, R ;

Lukas, MA ;

Anderson, KM ;

Bell, DSH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18) :2227-2236

[2] The importance of blood pressure control in the patient with diabetes [J].

Bakris, GL .

AMERICAN JOURNAL OF MEDICINE, 2004, 116 :30-38

[3] Triple Fixed-Dose Combination Therapy Back to the Past [J].

Black, Henry R. .

HYPERTENSION, 2009, 54 (01) :19-22

[4] Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide A Randomized Clinical Trial [J].

Calhoun, David A. ;

Lacourciere, Yves ;

Chiang, Yann Tong ;

Glazer, Robert D. .

HYPERTENSION, 2009, 54 (01) :32-39

[5] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

[6]

Crawford MH, 2009, AM J CARDIOVASC DRUG, V9, P1, DOI 10.2165/00129784-200909010-00001

[7]

Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393

[8] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].

Dahlöf, B ;

Sever, PS ;

Poulter, NR ;

Wedel, H ;

Beevers, DG ;

Caulfield, M ;

Collins, R ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J .

LANCET, 2005, 366 (9489) :895-906

[9] Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension [J].

Doulton, TWR ;

He, FJ ;

MacGregor, GA .

HYPERTENSION, 2005, 45 (05) :880-886

[10] Incident diabetes in clinical trials of anti hypertensive drugs: a network meta-analysis [J].

Elliott, William J. ;

Meyer, Peter M. .

LANCET, 2007, 369 (9557) :201-207

← 1 2 3 4 5 →